← FDA Drug Approvals (Drugs@FDA)

OLANZAPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: OMNIVIUM PHARMS · Approved 2026-01-23

Drug application

FDA Application #

ANDA219048

Application type

Abbreviated New Drug Application (Generic)

Brand name

OLANZAPINE

Generic name

Olanzapine

Active ingredients

OLANZAPINE

Dosage form

POWDER

Route

INTRAMUSCULAR

Marketing status

Prescription

Sponsor

OMNIVIUM PHARMS

First approval

2026-01-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown